ライブラリ登録: Guest
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集
Critical Reviews™ in Eukaryotic Gene Expression
インパクトファクター: 2.156 5年インパクトファクター: 2.255 SJR: 0.649 SNIP: 0.599 CiteScore™: 3

ISSN 印刷: 1045-4403
ISSN オンライン: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.2017018935
pages 53-62

Applications of Three-Dimensional Cell Cultures in the Early Stages of Drug Discovery, Focusing on Gene Expressions, Drug Metabolism, and Susceptibility

Ravi Maddaly
Department of Human Genetics, Faculty of Biomedical Sciences, Technology, and Research, Sri Ramachandra University, Porur, Chennai 600116, India

要約

Three-dimensional (3D) cell cultures represent advances in the way in which cells are grown in vitro, and they are gaining ground for a variety of applications. Advantages of 3D systems include reliable and realistic study endpoints. Cells grown in 3D conditions mimic in vivo conditions to an extent that is not possible with traditional 2D cell-culture methods. One major area in which 3D cell cultures have proven to make a difference is with drug discovery. The facets taken advantage of for drug discovery are the cells' complex microenvironment, including the production of extracellular matrices, altered gene expressions and their protein products, drug metabolism, and susceptibility to drugs when compared to 2D cultures. Altered protein and gene expressions are useful for drug-target identification. The susceptibility of 3D cultured cells for drug-induced effects can be used to obtain realistic data in a dose-dependent manner that can aid in identifying effective drug dosage. This review presents the contributions of 3D cell cultures for drug discovery, taking into consideration gene and protein expressions, drug metabolism, and susceptibility to drugs as the major focus points.


Articles with similar content:

The Tumor Microenvironment: A Target for Combination therapy of Breast Cancer
Critical Reviews™ in Oncogenesis, Vol.18, 2013, issue 1-2
Ralph A. Reisfeld
Identification of Peptides for Immunotherapy of Cancer. It is Still Worth the Effort
Critical Reviews™ in Immunology, Vol.18, 1998, issue 1-2
Sanne Weijzen, Markwin P. Velders, M. Fatima Macedo, W. Martin Kast, Michael P. Rudolf, John D. Nieland, Earin E. de Visser, Michele Carbone, Kathleen Loviscek
From Genes to Gene Medicines: Recent Advances in Nonviral Gene Delivery
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.15, 1998, issue 2
Alain P. Rolland
Options for the Treatment of Benign Prostatic Hyperplasia
Critical Reviews™ in Eukaryotic Gene Expression, Vol.22, 2012, issue 4
Scott Perrapato, Jared Wachterman, Mark Plante
Recent Developments of Biodegradable and Biocompatible Materials Based Micro/Nanoparticles for Delivering Macromolecular Therapeutics
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.26, 2009, issue 1
Guihua Huang, Yang Shi